Document:

<PAGE>

                            SPECIAL RETENTION PROGRAM
                            Administrative Guidelines
                   Under the Omnibus Stock and Incentive Plan

Purpose
-------
The Special Retention Program (SRP) allows for an equity grant, which is
designed to assist with the retention and motivation of key employees, in the
face of a highly competitive market for top talent. This program combines the
use of phantom restricted stock and payments in lieu of dividends (dividend
equivalents) to improve the retention value of Whirlpool's compensation
programs. Further, it provides an additional capital accumulation opportunity to
help retain a select group of high caliber, career minded key employees.

The phantom restricted stock is granted under the Company's Omnibus Stock and
Incentive Plans, and is governed by the terms and conditions of those plans.

The dividend equivalent awards are governed by the terms and conditions of the
Dividend Equivalent Plan document, and are paid out of the Company's general
funds or the Company's stock (treasury or newly issued).

Eligibility
-----------
Participation in the program will be limited to thirty-five to fifty officers of
the Corporation. Participants are recommended by the Office of the Chairman and
are approved by the Human Resources Committee of the Board of Directors.

Program Guidelines and Award Payments
-------------------------------------
Phantom Restricted Shares
Phantom restricted shares are awarded to participants by their classification
within tiers. Each tier has an approximate salary value as follows:
           Tier I ----- equals approximately four (4) times salary
           Tier II ---- equals approximately three (3) times salary
           Tier III --- equals approximately two (2) times salary
The Office of the Chairman initially determines the participants for each tier.

To arrive at the number of shares to be awarded, the approximate salary value is
divided by the share price (FMV) of the stock as of the day of the Human
Resource Committee meeting ($54.07).

Once granted, the phantom restricted shares will vest over a seven-year period.
The restrictions on the first 50% of the stock will lapse after the completion
of the third year, and the remaining 50% will lapse after the completion of the
seventh year of the program. As the restrictions lapse, the participants will
receive outright ownership of those shares.

                                        1

<PAGE>

Dividend Equivalents
Dividend equivalents may be paid on deferred phantom restricted shares until
either retirement or termination from the Company, at which time they will be
distributed to the participant.

Deferrals
---------
Once the restrictions on the phantom restricted shares have lapsed, they may be
deferred. These deferred shares will continue to maintain the characteristic of
stock, and as such, will accumulate dividend equivalents similar to any other
shares of Whirlpool stock. When retirement, or other termination from the
Company occurs, these deferred phantom shares and dividend equivalents will be
paid out at first distribution. All payments will be made as soon as
administratively feasible.

Tax Withholding
---------------
As with any other payment; the company has the obligation to withhold the
appropriate income taxes, FICA, or other social charges as required by the
governing tax jurisdiction. This withholding will be in the form of cash for
cash payments and in the form of shares for stock payments. For U.S.
participants, the federal supplemental tax rate (currently 28%) and the state
supplemental tax rate (if applicable) will be withheld. This will apply to
either cash or shares received.

Termination of Employment or Other Status Changes
-------------------------------------------------
In the case of death, retirement under the provisions of the applicable
Whirlpool (or subsidiary) pension plan, termination due to disability or
termination for any other reason; those phantom restricted shares whose
restrictions have not lapsed will be forfeited.

Non U.S. Participants
---------------------
In some jurisdictions, it may be necessary to use other vehicles in lieu of
phantom restricted shares. In those cases a similar vehicle may be granted in a
like amount. For example, performance units or other cash equivalents may be
used.

Beneficiary Designation
-----------------------
In the event of a participant's death, any benefits under the program will be
paid to the beneficiary named under the Omnibus Stock and Incentive plans in
accordance with the provisions of the grant document.

Change in Control
-----------------
If there is a change in control of Whirlpool Corporation, as defined in the
Company's Employee Pension Plan, all restrictions on the phantom restricted
shares will lapse and unrestricted shares will be delivered to the program
participants, provided they are Company employees, on the date that the change
of control occurs.

Administration
--------------
Corporate Compensation will be responsible for the overall administration of the
program.

                                        2

<PAGE>

They will maintain the record keeping for the eligible employees, including
participant's names, vesting schedules, dividend equivalent accumulations (where
applicable), changes in status and other relevant information as required. They
will also be responsible for determining the payments of stock, and accrued
dividends (if applicable).

The Corporate Legal department will be responsible for the issuance of any stock
payments under the phantom restricted share awards or deferral provisions of
this program. They will also maintain the appropriate record keeping.

Effective Date of the Program and Other Provisions
--------------------------------------------------
This program was approved by the Human Resources Committee of the Board of
Directors who retain the right to amend, modify or cancel its' provisions as
they deem appropriate. The program will be administered by the Corporate
Vice-President of Human Resources or his designated representative, and is
effective February 19, 2001.

Final Note
----------
These administrative guidelines provide for the fair and equitable
administration of the program on a year-to-year basis. These guidelines are
intended to clarify and supplement the provisions of the Corporation's Omnibus
Stock and Incentive Plans, which govern this program. Any statements contained
in this document that contradict the provisions of the Omnibus Plan document
will be considered inoperative, and the language in the relevant Omnibus Plan
document will control.

                                        3ex10-4

 

EXHIBIT 10.4

EMPLOYMENT AGREEMENT

ANTEX BIOLOGICS INC.

               THIS EMPLOYMENT AGREEMENT (the “Agreement”), made as of May 16, 2001 is
entered into by Antex Biologics Inc., a Delaware corporation with its principal
place of business at 300 Professional Drive, Gaithersburg, Maryland 20879 (the
“Company”), and Alan Liss, Ph.D., residing at 119 N. School Lane, Lancaster,
Pennsylvania 17603 (the “Employee”).

WITNESSETH:

               WHEREAS, the Company desires to employ the Employee, and the Employee
desires to be employed by the Company;

               NOW THEREFORE, in consideration of the mutual covenants and promises
contained herein, and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged by the parties hereto, the parties
agree as follows:

               1.     Term of Employment. The Company hereby agrees to employ the Employee,
and the Employee hereby accepts employment with the Company, upon the terms set
forth in this Agreement, for the period commencing on May 16, 2001 (the
“Commencement Date”) and ending on May 15, 2004 (such period, as it may be
extended, the “Employment Period”), unless sooner terminated in accordance with
the provisions of Section 4 hereof. Upon the third anniversary of the
Commencement Date and upon every third anniversary of the Commencement Date
thereafter, the term of the Employment Period shall be extended automatically
for three (3) additional years unless, at least six (6) months prior to such
anniversary, the Company shall have delivered to the Employee or, at least six
(6) months prior to such anniversary, the Employee shall have delivered to the
Company, written notice that the term of the Employee’s employment hereunder
will not be extended.

               2.     Title; Capacity. The Employee shall serve as Vice President, Product
Development or in such other position as the Company or its Board of Directors
(the “Board”) may determine from time to time. The Employee shall be based at
the Company’s headquarters in Gaithersburg, Maryland, or such place or places
in the continental United States as the Board shall determine. The Employee
shall be subject to the supervision of, and shall have such authority as is
delegated to him by, the Board or such officer of the Company as may be
designated by the Board.

               The Employee hereby accepts such employment and agrees to undertake the
duties and responsibilities inherent in such position and such other duties and
responsibilities as the Board or its designee shall from time to time
reasonably assign to him. The Employee agrees to devote his entire business
time, attention and energies to the business and interests of the Company
during the Employment Period. He shall not engage in any other business
activity, except as may be approved in writing by the Company. The Employee
agrees to abide by the rules, regulations, instructions, personnel practices
and policies of the Company and any changes

 

therein which may be adopted from time to time by the Company. The Employee
acknowledges receipt of copies of all such rules and policies committed to
writing as of the Commencement Date.

               3.     Compensation and Benefits.

                       3.1      Salary. The Company shall pay the Employee, in semi-monthly
installments on the 15th and month-end or on the last working day of such
month, an annual base salary (the “Annual Base Salary”) of One Hundred
Seventy-Five Thousand Dollars ($175,000) for the period commencing on the
Commencement Date. Thereafter, upon each anniversary of the Commencement Date
(including the first anniversary thereof), following an annual review by the
Board, the Board may adjust the Employee’s Annual Base Salary as it determines
in its sole discretion.

                     3.2      Fringe Benefits. The Employee shall be entitled to participate in all
bonus, stock option, benefit and insurance programs that the Company
establishes and makes available to its employees, if any, to the extent that
Employee’s position, tenure, salary, age, health and other qualifications make
him eligible to participate.

The Employee shall be entitled to twenty (20) days paid vacation per year, to
be taken at such times as may be approved by the Board or its designee.

                       3.3      Reimbursement of Expenses. The Company shall reimburse the Employee
for all reasonable travel, entertainment and other expenses incurred or paid by
the Employee in connection with, or related to, the performance of his duties,
responsibilities or services under this Agreement, upon presentation by the
Employee of documentation, expense statements, vouchers and/or such other
supporting information as the Company may request; provided, however, that the
amount available for such travel, entertainment and other expenses may be fixed
in advance by the Board.

                       3.4      Bonus. The Employer may, subject to approval of the Board, pay to the
Employee an appropriate performance bonus (the “Bonus”). The Bonus shall be
paid to Employee in one lump sum on or prior to May 31 of each year for the
one-year period of employment, or portion thereof, ending on the preceding
December 31.

               4.     Employment Termination. The employment of the Employee by the Company
pursuant to this Agreement shall terminate upon the occurrence of any of the
following:

                       4.1      Expiration of the Employment Period in accordance with Section 1
hereof and if the term is not extended in accordance with Section 1 hereof,
then the provisions of Section 4.4 hereof shall apply;

                       4.2      At the election of the Company, for cause, immediately upon written
notice by the Company to the Employee. For the purposes of this Section 4.2,
cause for termination shall be deemed to exist upon (a) a good faith finding by
the Company of failure of the Employee to perform his assigned duties for the
Company, dishonesty, gross negligence or

2

 

misconduct, or (b) the conviction of the Employee of, or the entry of a
pleading of guilty or nolo contendere by the Employee to, any crime involving
moral turpitude or any felony;

                       4.3      Upon the death or ninety (90) days after the disability of the
Employee. As used in this Agreement, the term “disability” shall mean the
inability of the Employee, due to a physical or mental disability, for a period
of ninety (90) days, whether or not consecutive, during any three hundred sixty
(360)-day period to perform the services contemplated under this Agreement. A
determination of disability shall be made by a physician satisfactory to both
the Employee and the Company, provided that if the Employee and the Company do
not agree on a physician, the Employee and the Company shall each select a
physician and these two together shall select a third physician, whose
determination as to disability shall be binding on all parties;

                       4.4      At the election of the Company, upon not less than six (6) months’
prior written notice of termination to the Employee. At the option of the
Company and in lieu of such notice, the Company may pay to Employee an amount
equal to (i) six (6) months’ salary computed on the basis of the then current
Annual Base Salary plus (ii) any bonus to which Employee is entitled. If the
Company elects to pay such amount in lieu of notice it shall, at the expense of
the Company, continue Employee’s participation in all benefits programs
including but not limited to medical, and life insurance programs provided by
the Company to the Employee under Section 3.2 hereof on the date on which such
amount is paid (the “Payment Date”) until a date six (6) months after the
Payment Date. In the event that Employee commences employment or
self-employment during the period the Company is making payments then the
salary payment maybe reduced by the amount the Employee receives through
employment or self-employment and the benefits will terminate on the date
Employee becomes eligible to participate in the benefits program pursuant to
employment or self-employment. The exercise of stock options and any
modifications to the exercise period will be in accordance with the Company’s
Amended and Restated Stock Option Plan.

                       4.5      At the election of the Employee, upon not less than six (6) months
prior written notice of termination to the Company.

               5.     Effect of Termination.

                         5.1      Termination for Cause or at Election of Either Party. In the event
the Employee’s employment is terminated for cause pursuant to Section 4.2
hereof, or at the election of the Employee pursuant to Section 4.5 hereof, the
Company shall pay to the Employee the compensation and benefits otherwise
payable to him under Section 3 hereof through the last day of his actual
employment by the Company.

                         5.2      Termination for Death or Disability. If the Employee’s employment is
terminated by death or because of disability pursuant to Section 4.3 hereof,
the Company shall pay to the estate of the Employee or to the Employee, as the
case may be, the compensation which would otherwise be payable to the Employee
up to the end of the month in which the termination of his employment because
of death or disability occurs.

3

 

                         5.3      Survival. The provisions of Sections 6 and 7 hereof shall survive the
termination of this Agreement.

               6.     Non-Competition.

                       (a)       During the Employment Period and for a period of two (2) years after
the termination or expiration thereof, the Employee will not directly or
indirectly:

		
	 	                    (i)      as an individual proprietor, partner, stockholder,
officer, employee, director, joint venturer, investor, lender, or
in any other capacity whatsoever (other than as the holder of not
more than one percent (1%) of the total outstanding stock of a
publicly held company), engage in the business of developing,
producing, marketing or selling products of the kind or type
developed or being developed, produced, marketed or sold by the
Company while the Employee was employed by the Company; or

		
	 	                    (ii)      recruit, solicit, or induce, or attempt to induce, any
employee or employees of the Company to terminate their employment
with, or otherwise cease their relationship with, the Company; or

		
	 	                    (iii)      solicit, divert or take away, or attempt to divert or
to take away, the business or patronage of any of the clients,
customers or accounts, or prospective clients, customers or
accounts, of the Company which were contacted, solicited or served
by the Employee while employed by the Company.

                       (b)       If any restriction set forth in this Section 6 is found by any court
of competent jurisdiction to be unenforceable because it extends for too long a
period of time or over too great a range of activities or in too broad a
geographic area, it shall be interpreted to extend only over the maximum period
of time, range of activities or geographic area as to which it may be
enforceable.

                       (c)       The restrictions contained in this Section 6 are necessary for the
protection of the business and goodwill of the Company and are considered by
the Employee to be reasonable for such purpose. The Employee agrees that any
breach of this Section 6 will cause the Company substantial and irrevocable
damage and therefore, in the event of any such breach, in addition to such
other remedies which may be available, the Company shall have the right to seek
specific performance and injunctive relief.

               7.     Proprietary Information and Development.

                       7.1      Proprietary Information.

                       (a)       Employee agrees that all information and know-how, whether or not in
writing, or of a private, secret or confidential nature concerning the
Company’s business or financial affairs (collectively, “Proprietary
Information”) is and shall be the exclusive property of the Company. By way of
illustration, but not limitation, Proprietary Information may include
inventions, products, processes, methods, techniques, formulas, compositions,
compounds,

4

 

projects, developments, plans, research data, clinical data, financial data,
personnel data, computer programs, and customer and supplier lists. Employee
will not disclose any Proprietary Information to others outside the Company or
use the same for any unauthorized purposes without written approval by the
President of the Company, either during or after his employment, unless and
until such Proprietary Information has become public knowledge without fault by
the Employee.

                       (b)       Employee agrees that all files, letters, memoranda, reports, records,
data, sketches, drawings, laboratory notebooks, program listings, or other
written, photographic, or other tangible material containing Proprietary
Information, whether created by the Employee or others, which shall come into
his custody or possession, shall be and are the exclusive property of the
Company to be used by the Employee only in the performance of his duties for
the Company.

                       (c)       Employee agrees that his obligation not to disclose or use
information, know-how and records of the types set forth in paragraphs (a) and
(b) above, also extends to such types of information, know-how, records and
tangible property of customers of the Company or suppliers to the Company or
other third parties who may have disclosed or entrusted the same to the Company
or to the Employee in the course of the Company’s business.

                       7.2      Developments.

                       (a)       Employee will make full and prompt disclosure to the Company of all
inventions, improvements, discoveries, methods, developments, software, and
works of authorship, whether patentable or not, which are created, made,
conceived or reduced to practice by the Employee or under his direction or
jointly with others during his employment by the Company, whether or not during
normal working hours or on the premises of the Company (all of which are
collectively referred to in this Agreement as “Developments”).

                       (b)       Employee agrees to assign and does hereby assign to the Company (or
any person or entity designated by the Company) all his right, title and
interest in and to all Developments and all related patents, patent
applications, copyrights and copyright applications. However, this Section 7.2
(b) shall not apply to Developments which do not relate to the present or
planned business or research and development of the Company and which are made
and conceived by the Employee not during normal working hours, not on the
Company’s premises and not using the Company’s tools, devices, equipment or
Proprietary Information.

                       (c)       Employee agrees to cooperate fully with the Company, both during and
after his employment with the Company, with respect to the procurement,
maintenance and enforcement of copyrights and patents (both in the United
States and foreign countries) relating to Developments. Employee shall sign
all papers, including, without limitation, copyright applications, patent
applications, declarations, oaths, formal assignments, assignment of priority
rights, and powers of attorney, which the Company may deem necessary or
desirable in order to protect its rights and interests in any Development.

                       7.3      Other Agreements. Employee hereby represents that he is not bound by
the terms of any agreement with any previous employer or other party to refrain
from

5

 

competing, or using or disclosing any trade secret or confidential or
proprietary information, directly or indirectly, related to the business of
such previous employer or other party, that does or could potentially conflict
with the performance of his duties and responsibilities with the Company.
Employee further represents that his performance of all terms of this Agreement
and as an employee of the Company does not and will not breach any agreement to
keep in confidence proprietary information, knowledge or data acquired by him
in confidence or in trust prior to his employment with the Company.

               8.     Notices. All notices required or permitted under this Agreement shall
be in writing and shall be deemed effective upon personal delivery or upon
deposit in the United States Post Office, by registered or certified mail,
postage prepaid, addressed to the other party at the address shown above, or at
such other address or addresses as either party shall designate to the other in
accordance with this Section 9.

               9.     Pronouns. Whenever the context may require, any pronouns used in this
Agreement shall include the corresponding masculine, feminine or neuter forms,
and the singular forms of nouns and pronouns shall include the plural, and vice
versa.

               10.     Entire Agreement. This Agreement constitutes the entire agreement
between the parties and supersedes all prior agreements and understandings,
whether written or oral, relating to the subject matter of this Agreement.

               11.     Amendment. This Agreement may be amended or modified only by a
written instrument executed by both the Company and the Employee.

               12.     Governing Law. This Agreement shall be construed, interpreted and
enforced in accordance with the laws of the State of Maryland.

               13.     Successors and Assigns. This Agreement shall be binding upon and
inure to the benefit of both parties and their respective successors and
assigns, including any corporation with which or into which the Company may be
merged to which may succeed to its assets or business, provided, however, that
the obligations of the Employee are personal and shall not be assigned by him.

               14.     Miscellaneous.

                        14.1      No delay or omission by the Company in exercising any right under
this Agreement shall operate as a waiver of that or any other right. A waiver
or consent given by the Company on any one occasion shall be effective only in
that instance and shall not be construed as a bar or waiver of any right on any
other occasion.

                        14.2      The captions of the sections of this Agreement are for convenience of
reference only and in no way define, limit of affect the scope or substance of
any section of this Agreement.

6

 

                        14.3      In case any provision of this Agreement shall be invalid, illegal or
otherwise unenforceable, the validity, legality and enforceability of the
remaining provisions shall in no way be affected or impaired thereby.

               IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the day and year set forth above.

	 	 	 
		 	
ANTEX BIOLOGICS INC.
	 
	 	 	
by  /s/ V. M. Esposito                             

     V. M. Esposito, Ph.D.

     Chairman of the Board of Directors

     and Chief Executive Officer
	 
	 	 	
Employee
	 
	 	 	
     /s/ Alan Liss                        
               

     Alan Liss, Ph.D.

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}]]